Cap
Latest Glaxo Group Limited Patents:
- Method of producing a recombinant protein
- Antigen binding proteins
- Pharmaceutical formulations comprising 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl) phenol
- Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist
- Compounds
Description
Claims
I claim the ornamental design for a cap, as shown and described.
Referenced Cited
U.S. Patent Documents
D243890 | March 29, 1977 | Yajima |
D263123 | February 23, 1982 | Hadtke et al. |
D354223 | January 10, 1995 | McIlvain |
D427520 | July 4, 2000 | Crawford |
D448994 | October 9, 2001 | Siebert et al. |
D475920 | June 17, 2003 | Poon et al. |
D475921 | June 17, 2003 | Smith |
D476887 | July 8, 2003 | Poisson et al. |
D477220 | July 15, 2003 | Poisson et al. |
D477221 | July 15, 2003 | Poisson et al. |
D489257 | May 4, 2004 | Braaten et al. |
D490314 | May 25, 2004 | Wadsworth et al. |
D495955 | September 14, 2004 | Storz et al. |
D541172 | April 24, 2007 | McConville et al. |
D548601 | August 14, 2007 | Mongeon et al. |
D553983 | October 30, 2007 | Bunce et al. |
D555000 | November 13, 2007 | Bunce et al. |
D556586 | December 4, 2007 | Mongeon et al. |
Patent History
Patent number: D573019
Type: Grant
Filed: Sep 26, 2006
Date of Patent: Jul 15, 2008
Assignee: Glaxo Group Limited (Greenford, Middlesex)
Inventor: Gary Spencer (London)
Primary Examiner: Gary D. Watson
Assistant Examiner: Susan B Hattan
Attorney: Nora Stein-Fernandez
Application Number: 29/266,663
Type: Grant
Filed: Sep 26, 2006
Date of Patent: Jul 15, 2008
Assignee: Glaxo Group Limited (Greenford, Middlesex)
Inventor: Gary Spencer (London)
Primary Examiner: Gary D. Watson
Assistant Examiner: Susan B Hattan
Attorney: Nora Stein-Fernandez
Application Number: 29/266,663
Classifications
Current U.S. Class:
D9/445